News

As per the terms of the agreement, the FDA will offer non-proprietary toxicology data for a variety of toxicological endpoints: including, carcinogenicity, developmental toxicity, genetic toxicity, and reproductive

Soligenix is developing stabilization technology under an option-to-license agreement from CU, which was executed to provide support $9.4m National Institute of Allergy and Infectious Diseases (NIAID) grant for

Under the deal, Abaxis supplies dry reagents using the company’s patented technology-Orbos Discrete Lyophilization Process (the Orbos Process) to BD. The contract enables the production of a precise

The company expects to recruit around 500 patients at 15 sites in China. Boston Scienific received CE Mark approval for the Promus Element Everolimus-Eluting Stent System in October

CCX832 is the fourth and final drug candidate discovered and developed by ChemoCentryx under its alliance with GlaxoSmithKline (GSK) to identify molecules targeting four specific chemokine and chemoattractant

As per the terms of the agreement, Teva Pharma has licensed APP Pharma to market Gemcitabine HCI for Injection in 200mg and 1g single dose vials during the

Mylan said that the generic name of Caduet tablets is Amlodipine Besylate/Atorvastatin Calcium tablets. Pursuant to the settlement agreement, pending litigation will be dismissed and Mylan may begin

Dupont said the new coverall performs three functions – protects the wearer, protects the products and processes, and offers comfort to the wearer. The Tyvek Labo coverall protects

The new license means that Android is now available for the symptomatic treatment of rheumatoid arthritis, osteoarthritis or ankylosing spondylitis. Axorid, which is to be taken as a